NEWS
See the latest PIR International News, Articles and Network Updates.
PIR International Supports Appointment of Chief Business Officer at CHARM Therapeutics
PIR International is pleased to announce the appointment of Beverley Carr as Chief Business Officer at CHARM Therapeutics. CHARM Therapeutics is a protein-ligand intelligence company turning advanced protein-ligand prediction into impactful medicines. CHARM’s advanced protein-ligand prediction platform, DragonFold, provides unique [...]
PIR International Supports Appointment of Non-Executive Chair at Closed Loop Medicine
PIR International is pleased to announce the appointment of Luba Greenwood as Non-Executive Chair at Closed Loop Medicine. Closed Loop Medicine is a TechBio company enhancing drug development through AI, machine learning, and personalized dosing, to bring forward the promise [...]
Aneesh Karatt Vellatt – BioLeader Interview
CSO & Co-Founder, Maxion Therapeutics (September 2024) Dr Aneesh Karatt Vellatt is Chief Scientific Officer and Co-Founder at Maxion Therapeutics Ltd (Cambridge UK), a company focused on developing antibody treatments for diseases driven by ion channels and GPCRs. Dr Karatt [...]
PIR International Supports Appointment of Non-Executive Chair at Anaveon
PIR International is pleased to announce the appointment of Dieter Weinand as Non-Executive Chair at Anaveon. Anaveon is a global clinical stage biopharmaceutical company that specializes in developing novel treatments for diseases with high unmet needs. The Company was founded [...]